HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinlong He Selected Research

chamazulene

2/2020Chamazulene reverses osteoarthritic inflammation through regulation of matrix metalloproteinases (MMPs) and NF-kβ pathway in in-vitro and in-vivo models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinlong He Research Topics

Disease

6Atherosclerosis
01/2021 - 12/2015
5Inflammation (Inflammations)
02/2020 - 07/2010
4Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 12/2015
3Hypertension (High Blood Pressure)
01/2020 - 05/2016
3Non-alcoholic Fatty Liver Disease
01/2019 - 05/2016
2Osteoarthritis
06/2022 - 01/2020
2Hyperhomocysteinemia
01/2019 - 01/2016
2Neointima
12/2018 - 12/2015
2Malocclusion (Crossbite)
02/2017 - 01/2017
1Infarction (Infarctions)
10/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2021
1Arthritis (Polyarthritis)
01/2021
1Rheumatoid Arthritis
01/2021
1Myocardial Infarction
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Knee Osteoarthritis
01/2021
1Venous Thromboembolism
01/2021
1Neoplasms (Cancer)
06/2020
1Edema (Dropsy)
01/2020
1Cardiotoxicity
01/2019
1Vascular System Injuries
12/2018
1Diabetes Mellitus
12/2018
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Reperfusion Injury
01/2017
1Metabolic Diseases (Metabolic Disease)
05/2016
1Cardiomegaly (Heart Hypertrophy)
05/2016
1Kidney Diseases (Kidney Disease)
05/2016

Drug/Important Bio-Agent (IBA)

4Epoxide HydrolasesIBA
01/2019 - 12/2015
3Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2018
3AcidsIBA
07/2017 - 12/2015
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2020
2Apolipoproteins E (ApoE)IBA
01/2021 - 01/2019
2NF-kappa B (NF-kB)IBA
01/2020 - 01/2016
2Dinoprostone (PGE2)FDA Link
01/2020 - 10/2019
2EicosanoidsIBA
01/2018 - 05/2016
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
06/2022
1Leukotriene B4IBA
10/2021
1triptolideIBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1ceramide kinaseIBA
01/2021
1AntithrombinsIBA
01/2021
1CeramidesIBA
01/2021
1Harmine (Telepathine)IBA
01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1Phosphates (Orthophosphate)IBA
01/2021
1Plasminogen Activators (Plasminogen Activator)IBA
01/2021
1Prothrombin (Factor II)IBA
01/2021
1SphingolipidsIBA
01/2021
1TabletsIBA
01/2021
1ThrombinFDA Link
01/2021
1Protein Tyrosine PhosphatasesIBA
01/2021
1graphene oxideIBA
01/2021
1Plasminogen Activator Inhibitor 1IBA
01/2021
1HydrogelsIBA
01/2021
1AntibodiesIBA
06/2020
1Matrix Metalloproteinases (MMPs)IBA
02/2020
1Freund's AdjuvantIBA
02/2020
1Interleukin-6 (Interleukin 6)IBA
02/2020
1chamazuleneIBA
02/2020
1Substance PIBA
01/2020
1Iodoacetic AcidIBA
01/2020
1CytokinesIBA
01/2020
1Matrix Metalloproteinase 13IBA
01/2020
1C-Reactive ProteinIBA
01/2020
1AdiponectinIBA
01/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Angiotensin IIIBA
10/2019
1Messenger RNA (mRNA)IBA
10/2019
1TOR Serine-Threonine KinasesIBA
10/2019
1Mechanistic Target of Rapamycin Complex 1IBA
10/2019
1Competitive Endogenous RNAIBA
01/2019
1LigandsIBA
01/2019
1Insulin Receptor Substrate ProteinsIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1IntegrinsIBA
01/2019
1bosutinibIBA
01/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019
1Advanced Glycation End ProductsIBA
01/2019
1Streptozocin (Streptozotocin)FDA Link
12/2018
1erucylphosphocholineIBA
12/2018
1LDL Receptors (LDL Receptor)IBA
01/2018
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2018
1Eicosapentaenoic AcidIBA
01/2018
1low density lipoprotein inhibitorIBA
01/2018
15-hydroxy-6,8,11,14,17-eicosapentaenoic acidIBA
07/2017
1Arachidonic Acid (Vitamin F)IBA
05/2016
1LipidsIBA
05/2016
1InflammasomesIBA
01/2016
1Adenosine Triphosphate (ATP)IBA
01/2016
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2016
120-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
06/2015
1Calcium Channels (Calcium Channel)IBA
06/2015

Therapy/Procedure

2Orthognathic Surgery
02/2017 - 01/2017
1Blood Transfusion (Blood Transfusions)
01/2021
1Injections
01/2021
1Length of Stay
01/2021
1Ligation
01/2021
1Knee Replacement Arthroplasty (Total Knee Replacement)
01/2021
1Intra-Articular Injections
01/2020